Ayurveda
BibhitakiTerminalia bellirica (also spelled bellerica)
The least-studied of triphala’s three fruits: we found no human gut trial of bibhitaki alone, only trials of triphala that include it.
- Botanical name
- Terminalia bellirica (also spelled bellerica)
- Part used
- fruit rind (dried fruit)
- Also called
- Sanskrit Bibhitaki, Vibhitaka, Aksha; Hindi Baheda; Beleric myrobalan, Bahera
- Used in
- Ayurveda
- Taken for
- Constipation, Loose stools and diarrhea, Indigestion
- Sold as
- powder (churna), capsules, tablets, extract, as part of triphala
What is meant by bibhitaki
Bibhitaki is the dried fruit of Terminalia bellirica (the spelling bellerica also appears), a large deciduous tree of India and Southeast Asia. The monograph lists the fruit rind, the seed and the seed kernel as parts used, with the dried rind the main one in triphala.
It is one of the three fruits in the formula triphala, alongside amla (amalaki) and haritaki. Outside the formula it is sold as a powder (churna), in capsules and tablets, and as an extract, and some Ayurvedic compounds use it in a mix with other astringent herbs. Most of what is published about bibhitaki in the gut is either laboratory work or studies of triphala as a whole. This entry says which is which.
In the traditions
Ayurveda (about Ayurveda)
An Ayurvedic college monograph lists the taste of bibhitaki as astringent, its qualities as dry and light, its potency as hot and its post-digestive effect as sweet. It describes the action as kapha-pittahara, meaning the tradition says it calms kapha and pitta. The monograph cites the Charaka Samhita for listing it among herbs that help purgation and among those for cough and fever, and the Sushruta Samhita for placing it in the triphala group. On the digestive uses, it says the half-ripe fruit is purgative, the ripe fruit is astringent, and a burnt-fruit preparation with salt is used for diarrhea. This is the tradition’s own account; the sources do not report measurements.
What the plant contains
Like the other two fruits, bibhitaki is rich in tannins and phenolic acids. A 2024 study profiled the small-molecule chemistry of all three triphala fruits. In lab work on gut bacteria, specific combinations of the three fruit extracts potentiated the inhibition of bacterial growth, which suggests the mix matters. Those are findings in culture dishes, and a lab effect on bacteria does not show what happens in a person’s gut.
What has been tested in people
We could not find a human trial of bibhitaki alone with a gut outcome. The human evidence that includes it is evidence for triphala as a whole.
An open-label study of 34 adults with functional constipation gave a powder of psyllium husk, senna extract and triphala extract for 14 days. Weekly bowel movements rose from 10.19 to 18.29, and Bristol stool score from 2.97 to 4.61. There was no placebo group, two of the three ingredients are well-known laxatives on their own, and bibhitaki is only one-third of the triphala extract, so the result cannot be credited to bibhitaki.
In a randomized, double-blind, placebo-controlled pilot, 31 healthy adults took 2,000 mg a day of triphala, 2,000 mg a day of manjistha (a different herb) or placebo for 4 weeks. The 29 who finished (9, 9 and 11) showed individual responses in their stool bacteria, with a trend toward more Akkermansia muciniphila and fewer Rikenellaceae in both herb groups. The abstract reports no symptom outcomes.
A narrative review of triphala’s uses and a 2018 review of triphala in functional gut disorders both treat the three fruits as one unit, and the 2018 review concluded the literature gives no clear evidence of an effect on the human digestive tract. Not tested in the sources we read: bibhitaki alone against placebo for any gut outcome, and the contribution of each fruit within triphala.
| Study | Dose | What it found |
|---|---|---|
| Open-label study, 34 adults with functional constipation (formula of psyllium husk, senna extract and triphala extract) PMID 22022157 | Powder formula, 14 days | Weekly bowel movements 10.19 to 18.29; no placebo; the result cannot be assigned to bibhitaki |
| Randomized, double-blind, placebo-controlled pilot of triphala, 31 healthy adults (29 analyzed) PMID 32955913 | 2,000 mg a day for 4 weeks | Individual changes in stool bacteria; trend to more Akkermansia; no symptom outcomes in the abstract |
| Review of triphala in functional gastrointestinal disorders (2018) PMID 30034512 | Various | No clear evidence for the human digestive tract; the fruits are treated as one formula |
| Lab study of triphala component extracts and gut bacterial growth PMID 32464314 | In culture, not a human trial | Specific combinations of the three fruit extracts potentiated the inhibition of gut bacterial growth |
Doses used in trials and traditional preparations
No source we read gives a trial dose of bibhitaki alone for the gut. The triphala pilot used 2,000 mg a day of the three-fruit mixture for 4 weeks, so any bibhitaki content was a fraction of that. Ayurvedic practice uses the dried rind as a powder in water or a decoction, and as one component of triphala. The Ayurvedic literature on triphala ties its effect to the amount: a tonic at small amounts, a mild laxative at ordinary amounts and a purgative at large amounts.
Treat these figures as a record of what was studied. Whether any amount of bibhitaki suits a particular person is a question for a clinician or pharmacist who knows their history.
Safety
The reviews of triphala report no side effects in treated groups of the studies they cite, but those studies used all three fruits. We found no separate safety trials of bibhitaki, nor any in pregnancy, breastfeeding or children. The monograph describes the half-ripe fruit as purgative, so cramping and loose stools are the expected effect of large amounts.
On contamination, a 2008 study of 193 Ayurvedic products sold online found 20.7% had detectable lead, mercury or arsenic, against 40.6% of the metal-based rasa shastra products, and CDC documented 12 adult lead poisoning cases tied to Ayurvedic remedies across five states in 2000 to 2003. Those studies did not name bibhitaki, and plain fruit powders are not the metal-containing class.
Drug interactions
We found no interaction studies of bibhitaki in people. The same applies to triphala, so the reviews give no medicine classes to flag. Because large amounts are described as purgative, faster bowel transit is the plausible way a bibhitaki product could change how much of another oral medicine is absorbed. That is an inference from the herb’s traditional action, not a documented interaction.
Prescriptions flagged alongside bibhitaki
Published interaction references put these medicines next to this herb, and the quiz acts on them; a pharmacist is the person to confirm any of it:
- canagliflozin (flagged to check)
- dapagliflozin (flagged to check)
- empagliflozin (flagged to check)
- glimepiride (flagged to check)
- glipizide (flagged to check)
- glyburide (flagged to check)
- insulin (flagged to check)
- liraglutide (flagged to check)
- metforman (flagged to check)
- metformin (flagged to check)
- pioglitazone (flagged to check)
- semaglutide (flagged to check)
- sitagliptin (flagged to check)
- tirzepatide (flagged to check)
Products in the catalog with bibhitaki
These catalog entries list bibhitaki or one of its preparations among their active ingredients. Each page shows the amount on the label, the trials behind it and what buyers report.
Is a bibhitaki product right for you?
Answer a few questions about your symptoms, routine and medicines, and the quiz names one product, with the reasons it won.
Take the quizRelated herbs
Common questions
What is bibhitaki?
It is the dried fruit of Terminalia bellirica, one of the three fruits in triphala along with amla and haritaki. In Hindi it is called baheda.
Does bibhitaki help constipation?
We found no human trial of bibhitaki alone. The trials that include it test triphala or a mixed formula. In an open-label study of a psyllium, senna and triphala powder, weekly bowel movements rose from 10.19 to 18.29, but the result cannot be assigned to one fruit.
Why does Ayurveda call it kapha-pitta calming?
Kapha and pitta are two of the three body types in Ayurveda. The tradition assigns each herb an action on them, and the monograph lists bibhitaki as kapha-pittahara. It is a classification the tradition applies, not a measured effect.
Is bibhitaki used for diarrhea or for constipation?
Both, according to a traditional monograph: the half-ripe fruit is described as purgative and the ripe fruit as astringent, and a burnt-fruit preparation is listed for diarrhea. We found no trial testing either use.
How can a shopper tell what is in a triphala product?
The label may name the three fruits without giving their ratio. Proportions of the three fruits vary between formulations, and the 2018 review describes animal work comparing them, so two triphala products can contain different amounts of bibhitaki.
Sources
- Dravyaguna Vigyan monograph series, "Bibhitaka (Terminalia bellirica Roxb.)", sdach.ac.in (Ayurvedic college monograph: tastes, qualities, potency, classical references, uses) www.sdach.ac.in/dravyaguna-vigyan-blogs/bibhitaka
- Munshi R et al., "An open-label, prospective clinical study to evaluate the efficacy and safety of TLPL/AY/01/2008 in the management of functional constipation", J Ayurveda Integr Med 2011;2(3):144-152 pubmed.ncbi.nlm.nih.gov/22022157
- Peterson CT et al., "Modulatory Effects of Triphala and Manjistha Dietary Supplementation on Human Gut Microbiota: A Double-Blind, Randomized, Placebo-Controlled Pilot Study", J Altern Complement Med 2020;26(11):1015-1024 pubmed.ncbi.nlm.nih.gov/32955913
- Peterson CT, Denniston K, Chopra D, "Therapeutic Uses of Triphala in Ayurvedic Medicine", J Altern Complement Med 2017;23(8):607-614 pubmed.ncbi.nlm.nih.gov/28696777
- Tarasiuk A, Mosinska P, Fichna J, "Triphala: current applications and new perspectives on the treatment of functional gastrointestinal disorders", Chin Med 2018;13:39 pubmed.ncbi.nlm.nih.gov/30034512
- Tiwana G et al., "Use of specific combinations of the triphala plant component extracts to potentiate the inhibition of gastrointestinal bacterial growth", J Ethnopharmacol 2020;260:112937 pubmed.ncbi.nlm.nih.gov/32464314
- Hegde SN et al., "A comprehensive metabolome profiling of Terminalia chebula, Terminalia bellerica, and Phyllanthus emblica to explore the medicinal potential of Triphala", Sci Rep 2024;14:31635 pubmed.ncbi.nlm.nih.gov/39738152
- Saper RB et al., "Lead, mercury, and arsenic in US- and Indian-manufactured Ayurvedic medicines sold via the Internet", JAMA 2008;300(8):915-923 pubmed.ncbi.nlm.nih.gov/18728265
- Centers for Disease Control and Prevention, "Lead poisoning associated with ayurvedic medications, five states, 2000-2003", MMWR 2004;53(26):582-584 pubmed.ncbi.nlm.nih.gov/15241300